John M. Reher
John M. Reher has been president and executive director of Accelerate Brain Cancer Cure, Inc(ABC2) from 2001-2006. ABC2 is a non-profit organization dedicated to accelerating therapies for treatment of brain cancer by employing venture principles to this philanthropic endeavor.
Mr. Reher previously had over twelve years of venture capital experience, as a general partner and co-founder of Medicus Venture Partners, an early stage healthcare venture partnership, with investments including Biosite Diagnostics, Inhale Therapeutic Systems (now Nektar), Tularik, and other successful companies.
Before entering the venture industry in 1989, Mr. Reher held financial, marketing, licensing, acquisitions and overall team leader positions for Genentech (1982-1989) and G.D. Searle Pharmaceuticals (1974-1981).
Mr. Reher has taught college courses in Economics, Finance and Investments. He received a Masters of Management degree from Northwestern University and a B.S. in Mathematics and Business Economics from Illinois Benedictine University.